Medical Science Liaison MSL role evolution KOL engagement pharmaceutical industry trends MSL recruitment trends

The MSL - 4 Years, 200 Episodes…What’s new, What’s not

by MSL Talk: Tom Caravela, Sarah Snyder
· The Carolan Group

Apr 9^th 2024
33 mins
E200

Share This Article

Summary

In this milestone 200th episode, Tom Caravela welcomes Sarah Snyder to delve into the evolving landscape of the Medical Science Liaison (MSL) role. Sarah shares insights from her experience, reflecting on the changes in MSL roles, titles, and key opinion leader engagement over the past four years. The discussion covers technological advancements and recruitment trends, highlighting the growing importance of MSLs in the pharmaceutical industry. Despite the lack of standardization in roles, Sarah contrasts experiences in large versus small companies and offers predictions for the future of medical affairs. The episode concludes with reflections on the significance of MSLs and gratitude to listeners.

Sarah Snyder, MSL Recruiter with The Carolan Group discusses how the MSL role has changed in the past 4 years, and how it has not.

Learn more about…

👉 Changes in KOL Engagement and Access
👉 Titles, Responsibilities and Career Ladder
👉 Resources that have emerged for MSLs (including tech and tools)
👉 What changes in hiring practices have emerged
👉 The MSL job market and factors that have affected it
👉 The universal standard for MSLs